Glaxosmithkline
May 16, 2012 at 14:42 | Source: Moneycontrol.com
May 07, 2012 at 18:00 | Source: Moneycontrol.com
May 07, 2012 at 15:19 | Source: Moneycontrol.com
May 07, 2012 at 14:27 | Source: Moneycontrol.com
May 07, 2012 at 08:05 | Source: CNBC-TV18
Videos »
Photos »
/ 
News across the web »
May 25, 2012 at 16:22 | Source: Market Watch
May 25, 2012 at 03:11 | Source: Forbes
May 24, 2012 at 06:00 | Source: Business Week
May 23, 2012 at 07:51 | Source: Economic Times
May 22, 2012 at 22:11 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
Related News »
GlaxoSmithKline PLC (GSK) - Transaction in Own Shares RNS Number : 3596E GlaxoSmithKline PLC 29 May 2012 GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual ...
May 29, 2012 at 16:49 | Source: Bloomberg
GlaxoSmithKline PLC (GSK) - Director/PDMR Shareholding RNS Number : 3621E GlaxoSmithKline PLC 29 May 2012 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons ...
May 29, 2012 at 17:25 | Source: Bloomberg
(RTTNews) - GlaxoSmithKline plc (GSK: News ,GSK.L: News ) Wednesday amended the conditions of its unsolicited tender offer to acquire Human Genome Sciences (HGSI: News ) for $13.00 per share. The move, the British drug maker said, is in response to a ...
May 23, 2012 at 17:25 | Source: RTT News
Howell filed his suit in frustration after GlaxoSmithKline said Wednesday May 23 that it would not proceed with its $13-a-share offer direct to investors unless Rockville, Md.-based Human Genome's board dropped the shareholder rights plan.
May 29, 2012 at 14:47 | Source: The Business Journal
NEW YORK (AP) -- British drug maker GlaxoSmithKline PLC has closed on a deal that boosts its interest in biotechnology company Theravance Inc. by 10 million shares. Theravance's shareholders approved the transaction on Tuesday. Last month ...
May 29, 2012 at 02:23 | Source: Yahoo Finance
GlaxoSmithKline PLC (>> GlaxoSmithKline plc), a global healthcare group, said Tuesday it purchased 1.8 million of its ordinary shares of 25 pence each, adding that it intends to hold these shares in treasury. -The highest price paid per Share was 1,440.5 ...
May 29, 2012 at 16:42 | Source: 4-traders (press release)
After failing to reach a buyout deal with Human Genome Sciences (HGSI), GlaxoSmithKline (GSK) will now make a cash tender offer to the company's shareholders for $13 per share. Considering Human Genome Sciences' top ten shareholders own 78% of the company ...
May 14, 2012 at 17:00 | Source: Seekingalpha.com
LONDON (Reuters) - Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set to steal a march on Roche's pioneering melanoma treatment Zelboraf, according to Citigroup. The brokerage ...
May 28, 2012 at 13:08 | Source: YAHOO!
Tuesday, May 22, 2012... GlaxoSmithKline PLC (NYSE:GSK) closed Monday's bullish trading session at $44.48. In the past year, the stock has hit a 52-week low of $38.76 and..... Wednesday, May 16, 2012... GlaxoSmithKline PLC (NYSE:GSK) closed Tuesday's ...
May 29, 2012 at 11:55 | Source: Market Intelligence Center
The Centre for Drug Research and Development (CDRD), its commercial arm, CDRD Ventures Inc. (CVI), and GlaxoSmithKline (GSK) in Canada are pleased to announce they have entered into a strategic collaboration that will provide new financial resources as ...
May 29, 2012 at 19:26 | Source: msnbc.com